Immunotherapy in Translational Cancer Research, , Wiley, John Wiley & Sons,Oncology,Diseases and disorders, The role of translational biomarkers in clinical use of immunotherapy for cancer; monoclonal antibody therapy; somatic mutations and immunotherapy; myeloid leukemia vaccines; cancer vaccines for solid tumors; cancer vaccines strategies; multiple peptide vaccines; full protein vaccines; tumor cell vaccines; immunotherapy with non-genetically modified T cells; tumor-infiltrating lymphocyte therapy; immunotherapy with genetically modified T cells; methods of tumor immune evasion; genetically modified TCRs for adoptive cellular therapy; chronic lymphocytic leukemia; non-Hodgkin lymphoma; immunomodulation with adjuvants and cytokines; glucocorticoid-induced TNFR-related protein; immune cell migration in cancer and immunotherapy; repurposing of drugs for immunotherapy; DNMT inhibitors; HDAC inhibitors; non-steroidal and inflammatory drugs; Adoptive T cell therapy; Chimeric antigen receptors; Antibody-dependent cellular cytotoxicity; Hematopoietic stem cell transplantation; Immune checkpoint blockade,, Translational Oncology, United States, en-UShttps://www.wiley.comThe role of translational biomarkers in clinical use of immunotherapy for cancer; monoclonal antibody therapy; somatic mutations and immunotherapy; myeloid leukemia vaccines; cancer vaccines for solid tumors; cancer vaccines strategies; multiple peptide vaccines; full protein vaccines; tumor cell vaccines; immunotherapy with non-genetically modified T cells; tumor-infiltrating lymphocyte therapy; immunotherapy with genetically modified T cells; methods of tumor immune evasion; genetically modified TCRs for adoptive cellular therapy; chronic lymphocytic leukemia; non-Hodgkin lymphoma; immunomodulation with adjuvants and cytokines; glucocorticoid-induced TNFR-related protein; immune cell migration in cancer and immunotherapy; repurposing of drugs for immunotherapy; DNMT inhibitors; HDAC inhibitors; non-steroidal and inflammatory drugs; Adoptive T cell therapy; Chimeric antigen receptors; Antibody-dependent cellular cytotoxicity; Hematopoietic stem cell transplantation; Immune checkpoint blockade, [BLURB],[CITY],,books, ebooks, biblet, Book2look